Actively Recruiting

Phase Not Applicable
Age: 19Years +
All Genders
ID06700304

CAN-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

Led by Neuralink Corp · Updated on 2025-05-31

6

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

Sponsors

N

Neuralink Corp

Lead Sponsor

U

University Health Network, Toronto

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the safety and function of Neuralink's N1 Implant and R1 Robot in people who have difficulty moving their arms and legs due to conditions like tetraplegia or tetraparesis. The study aims to understand how well this brain-computer interface and its robotic implantation system work in individuals who have severe movement impairments, including those with spinal cord injury or amyotrophic lateral sclerosis (ALS). The N1 Implant is a small, wireless device placed inside the skull and connected to tiny threads inserted into the brain by the R1 Robot, a machine designed to precisely implant these threads. This is an open-label study where participants receive the implant and robot-assisted procedure to explore the device's performance and safety over time. Participants will be closely monitored through multiple assessments over 12 months post-implant, including tracking device- and procedure-related adverse events. Cognitive and mental health evaluations using tools like the Montreal Cognitive Assessment (MoCA), Patient Health Questionnaire-9 (PHQ-9), and Generalized Anxiety Disorder-7 (GAD-7) will be done at regular intervals up to 36 months. The study involves ongoing follow-up to assess long-term effects and safety.

CONDITIONS

Brief Title

CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Severe quadriplegia (tetraplegia) due to spinal cord injury or amyotrophic lateral sclerosis (ALS) for at least 1 year without improvement
  • Life expectancy of at least 12 months
  • Ability to communicate in English
  • Presence of a stable caregiver
Not Eligible

You will not qualify if you...

  • Moderate to high risk for serious perioperative adverse events
  • Active implanted devices
  • Morbid obesity (Body Mass Index > 40)
  • History of poorly controlled seizures or epilepsy
  • History of poorly controlled diabetes
  • Requires magnetic resonance imaging (MRI) for any ongoing medical conditions
  • Acquired or hereditary immunosuppression
  • Use of smoking tobacco or other tobacco products
  • Psychiatric or psychological disorder
  • Brain MRI showing hemorrhage, tumor, distorted or adverse anatomy
  • Any condition compromising safe participation or implantation as judged by the Investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Day of surgery and immediate recovery period

Participants undergo robotic implantation of the N1 brain-computer interface device using the R1 Robot.

1 implantation visit and several immediate post-operative visits

Post-operative Follow-up

Duration - Up to 12 months post-implant

Participants are monitored for device- and procedure-related adverse events and cognitive and psychological assessments are conducted up to 12 months post-implantation.

Multiple visits including assessments at 3, 6, 9, and 12 months post-implantation

Long-term Monitoring

Duration - Up to 36 months post-implant

Participants continue to be monitored for safety and cognitive and psychological outcomes up to 36 months post-implantation.

Periodic visits up to 36 months post-implantation

Trial Site Locations

Total: 1 location

1

University Health Network

Toronto, Ontario, Canada, M5G 2C4

Actively Recruiting

Loading map...

Research Team

N

Neuralink Clinical Team

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Similar Trials

Phase 1 Study to Evaluate [18F]ACI-19626 as a PET Radioligan...

Frontotemporal Dementia (FTD)

Actively Recruiting

1 location

A Phase 1b/2 Study to Evaluate NB-4746 in Participants With ...

Amyotrophic Lateral Sclerosis (ALS)

Actively Recruiting

6 locations

A Neuroprosthesis for Seated Posture and Balance

Spinal Cord Injury

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here